Salvador Augustín

8.5k total citations · 1 hit paper
90 papers, 3.3k citations indexed

About

Salvador Augustín is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Salvador Augustín has authored 90 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 62 papers in Hepatology and 31 papers in Surgery. Recurrent topics in Salvador Augustín's work include Liver Disease Diagnosis and Treatment (74 papers), Liver Disease and Transplantation (54 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Salvador Augustín is often cited by papers focused on Liver Disease Diagnosis and Treatment (74 papers), Liver Disease and Transplantation (54 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Salvador Augustín collaborates with scholars based in Spain, United States and Canada. Salvador Augustín's co-authors include Joan Genescà, Juan G. Abraldeṣ, Jaime Bosch, Juan Carlos García‐Pagán, Annalisa Berzigotti, Rafael Bañares, Càndid Villanueva, Agustı́n Albillos, José Luís Calleja and Antonio González and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Salvador Augustín

89 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

2019 392 citations Càndid Villanueva, Agustı́n Albillos et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salvador Augustín Spain	28	2.7k	2.6k	1.2k	204	194	90	3.3k
Daniel S. Matloff United States	22	2.8k 1.1×	2.9k 1.1×	1.3k 1.1×	120 0.6×	144 0.7×	32	3.4k
Antoni Mas Spain	32	2.0k 0.7×	2.4k 1.0×	1.0k 0.8×	103 0.5×	176 0.9×	83	3.3k
Jiannis Vlachogiannakos Greece	31	1.8k 0.7×	1.7k 0.6×	1.2k 1.0×	120 0.6×	78 0.4×	109	3.0k
Kiran Bambha United States	23	1.4k 0.5×	1.3k 0.5×	729 0.6×	149 0.7×	278 1.4×	50	2.0k
Isabel Cirera Spain	28	1.8k 0.7×	2.1k 0.8×	1.1k 0.9×	109 0.5×	61 0.3×	70	2.8k
Julien Massard France	21	2.0k 0.7×	1.6k 0.6×	447 0.4×	86 0.4×	474 2.4×	36	2.4k
Rakhi Maiwall India	30	1.6k 0.6×	1.8k 0.7×	722 0.6×	105 0.5×	93 0.5×	140	2.7k
Elsa Solà Spain	35	2.9k 1.1×	3.8k 1.5×	1.5k 1.3×	104 0.5×	84 0.4×	91	4.5k
Àngels Escorsell Spain	38	5.7k 2.1×	6.3k 2.5×	3.8k 3.1×	205 1.0×	227 1.2×	97	7.3k
Luís Ruíz-del-Árbol Spain	16	2.7k 1.0×	3.2k 1.2×	1.7k 1.4×	58 0.3×	62 0.3×	24	3.7k

Countries citing papers authored by Salvador Augustín

Since Specialization

Citations

This map shows the geographic impact of Salvador Augustín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvador Augustín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvador Augustín more than expected).

Fields of papers citing papers by Salvador Augustín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvador Augustín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvador Augustín. The network helps show where Salvador Augustín may publish in the future.

Co-authorship network of co-authors of Salvador Augustín

This figure shows the co-authorship network connecting the top 25 collaborators of Salvador Augustín. A scholar is included among the top collaborators of Salvador Augustín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvador Augustín. Salvador Augustín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Villanueva, Càndid, Joan Genescà, Juan Carlos García‐Pagán, et al.. (2024). Progressive systemic inflammation precedes decompensation in compensated cirrhosis. JHEP Reports. 7(2). 101231–101231. 4 indexed citations

Augustín, Salvador, et al.. (2024). Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review. Journal of Molecular Medicine. 102(7). 841–858. 6 indexed citations

Rivera‐Esteban, Jesús, Mònica Pons, Ramiro Manzano-Núñez, et al.. (2023). Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes. Gastroenterología y Hepatología (English Edition). 46(9). 682–691. 1 indexed citations

Pons, Mònica, Jesús Rivera‐Esteban, Mang Ma, et al.. (2023). Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 22(8). 1637–1645.e9. 27 indexed citations

Romero‐Gómez, Manuel, R. Aller, Javier Ampuero, et al.. (2023). AEEH "Consensus about detection and referral of hidden prevalent liver diseases". Gastroenterología y Hepatología (English Edition). 46(3). 236–247. 2 indexed citations

Rivera‐Esteban, Jesús, Sergio Muñoz, Salvador Augustín, et al.. (2023). Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study. Journal of Clinical Medicine. 12(23). 7276–7276. 6 indexed citations

Ratziu, Vlad, Quentin M. Anstee, Vincent Wai‐Sun Wong, et al.. (2022). An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project. Hepatology. 76(6). 1766–1777. 8 indexed citations

Rivera‐Esteban, Jesús, Mònica Pons, Ramiro Manzano-Núñez, et al.. (2022). Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes. Gastroenterología y Hepatología. 46(9). 682–691. 4 indexed citations

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2021). Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. Journal of Hepatology. 75(3). 589–599. 39 indexed citations

10.

Rivera‐Esteban, Jesús, Angelo Armandi, Salvador Augustín, & Elisabetta Bugianesi. (2021). Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis. Liver International. 41(9). 1999–2008. 7 indexed citations

11.

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2019). β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 393(10181). 1597–1608. 392 indexed citations breakdown →

12.

Pons, Mònica, Sergio Rodríguez‐Tajes, Juan Ignacio Esteban, et al.. (2019). Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals. Journal of Hepatology. 72(3). 472–480. 121 indexed citations

13.

García‐Lezana, Teresa, Imma Raurell, Miren Bravo, et al.. (2017). Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. Hepatology. 67(4). 1485–1498. 101 indexed citations

14.

Pons, Mònica, Macarena Simón‐Talero, Laura Millán, et al.. (2016). Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease. Digestive and Liver Disease. 48(10). 1214–1219. 12 indexed citations

15.

Villanueva, Càndid, Agustı́n Albillos, Joan Genescà, et al.. (2015). Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension. Hepatology. 63(1). 197–206. 132 indexed citations

16.

Riera, Jordi, Berta Caralt, Salvador Augustín, et al.. (2014). Complications in the Immediate Postoperatory of Lung Transplantation: Three Years of Practice at a High-Experienced Center. CHEST Journal. 145(3). 631A–631A. 2 indexed citations

17.

Simón‐Talero, Macarena, Rita García‐Martínez, María Torrens, et al.. (2013). Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study. Journal of Hepatology. 59(6). 1184–1192. 88 indexed citations

18.

Foruria, Antonio M., Salvador Augustín, B.F. Morrey, & Joaquín Sánchez‐Sotelo. (2013). Heterotopic Ossification After Surgery for Fractures and Fracture-Dislocations Involving the Proximal Aspect of the Radius or Ulna. Journal of Bone and Joint Surgery. 95(10). e66–1. 96 indexed citations

19.

Augustín, Salvador, Laura Millán, Antonio González, et al.. (2013). Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: A prospective study. Journal of Hepatology. 60(3). 561–569. 105 indexed citations

20.

Altamirano, José, Salvador Augustín, Antonio González, et al.. (2010). High doses of β-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding. Liver International. 30(8). 1123–1130. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact